Search Within

Glenn Heller

Formats
  1. Journal Article (268)
  2. Meeting Abstract (123)
  3. Conference Paper (9)
Groups
  1. Biostatistics Service (400)
  2. Epidemiology and Biostatistics (400)
  3. Department of Medicine (300)
  4. GSK Faculty (193)
  5. Center for Hematologic Malignancies (162)
  6. Pediatrics, Department of (158)

More Groups

People
  1. Howard Scher (89)
  2. Richard O'Reilly (75)
  3. Nancy Kernan (59)
  4. Michael Morris (54)
  5. James Young (52)
  6. Marcel Van Den Brink (47)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (9)
  4. 2022 (9)
  5. 2021 (9)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (82)
  2. Blood (69)
  3. Biology of Blood and Marrow Transplantation (32)
  4. Clinical Cancer Research (24)
  5. Bone Marrow Transplantation (13)
  6. Cancer (13)

More Publications

Publishers
  1. American Society of Clinical Oncology (84)
  2. American Society of Hematology (70)
  3. Elsevier Inc. (41)
  4. American Association for Cancer Research (40)
  5. Nature Publishing Group (26)
  6. Elsevier Science, Inc. (24)

More Publishers

Results (400)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) PET as a prognostic biomarker for survival in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Jia, X.; Heller, G.; Schoder, H.; Humm, J.; Haupt, E. C.; Schneider, C.; Scher, H. I.; Larson, S. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Does the catalytic activity of prostate-specific antigen (PSA) or kallikrein-related peptidase 2 (hK2) secreted by novel transgenic mice models critically influence development of prostate cancer or release of PSA or hK2 in blood
    Meeting Abstract

    Braun, K.; Ulmert, D.; von Bodman, C.; Byers, A.; Mehta, D.; Johnson, L.; Wenske, S.; Hricik, T.; Heller, G.; Scher, H.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • The analytical validation of prostate specific mRNA detection in whole blood by reverse transcription-polymerase chain reaction (RT-PCR) as a prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
    Journal Article

    Tarek, N.; Luduec, J. B. L.; Gallagher, M. M.; Zheng, J.; Venstrom, J. M.; Chamberlain, E.; Modak, S.; Heller, G.; Dupont, B.; Cheung, N. K. V.; more...
    Journal of Clinical Investigation (2012)

    Fulltext@MSK | Save
  • Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1
    Journal Article

    Romano, E.; Cotari, J. W.; da Silva, R. B.; Betts, B. C.; Chung, D. J.; Avogadri, F.; Fink, M. J.; St Angelo, E. T.; Mehrara, B.; Heller, G.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Factors associated with relapse and survival in Wilms tumor: A multivariate analysis
    Journal Article

    Honeyman, J. N.; Rich, B. S.; McEvoy, M. P.; Knowles, M. A.; Heller, G.; Riachy, E.; Kobos, R.; Shukla, N.; Wolden, S. L.; Steinherz, P. G.; more...
    Journal of Pediatric Surgery (2012)

    Fulltext@MSK | Save
  • A phase I trial of docetaxel and pulse-dose 17-allylamino-17- demethoxygeldanamycin in adult patients with solid tumors
    Journal Article

    Iyer, G.; Morris, M. J.; Rathkopf, D.; Slovin, S. F.; Steers, M.; Larson, S. M.; Schwartz, L. H.; Curley, T.; Delacruz, A.; Ye, Q.; more...
    Cancer Chemotherapy and Pharmacology (2012)

    Fulltext@MSK | Save
  • The use of back-up units to enhance the safety of unrelated donor cord blood transplantation
    Journal Article

    Ponce, D. M.; Lubin, M.; Gonzales, A. M.; Byam, C.; Wells, D.; Ferrante, R.; Heller, G.; Giralt, S.; Papadopoulos, E. B.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • A measure of explained risk in the proportional hazards model
    Journal Article

    Heller, G.
    Biostatistics (2012)

    Fulltext@MSK | Save
  • Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV(+) lymphomas after allogeneic hematopoietic cell transplantation
    Journal Article

    Doubrovina, E.; Oflaz-Sozmen, B.; Prockop, S. E.; Kernan, N. A.; Abramson, S.; Teruya-Feldstein, J.; Hedvat, C.; Chou, J. F.; Heller, G.; Barker, J. N.; more...
    Blood (2012)

    Fulltext@MSK | Save